Source: Getty Images Patients who underwent the minimally invasive procedure had a 36%, 50%, and 44% improvement in IPSS, quality of life, and peak flow rate, respectively, at 5 years. Prostatic ...

Post-marketing data show that prostatic urethral lift provides symptom relief in patients outside of the controlled clinical trial setting. Prostatic urethral lift (PUL) improves lower urinary tract ...

DEAR DR. ROACH: I am a 66-year old male, who is healthy with a very active life, both physical and sexual. Like many men my age, I have an enlarged prostate that my doctor monitors during annual ...

Dear Dr. Roach: I am a 66-year old male, who is healthy with a very active life, both physical and sexual. Like many men my age, I have an enlarged prostate that my doctor monitors during annual ...

WAYNE, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the presentation of new clinical data at the American Urological Association (AUA) 2019 Annual Meeting ...

I am a 66-year old male, who is healthy with a very active life, both physical and sexual. Like many men my age, I have an enlarged prostate that my doctor monitors during annual visits. It doesn't ...

Late-Breaking Data Presentation Reveals How UroLift PUL’s Post-Operative Events Compare With Other Minimally Invasive Procedures and Traditional Surgery for the Treatment of BPH WAYNE, Pa., Sept. 14, ...

Expanding the urethral lumen by mechanically separating the encroaching prostatic lobes is a safe and simple means of providing rapid relief from lower urinary tract symptoms (LUTS) secondary to ...

Even kings have prostate problems. King Charles III was admitted on Friday to The London Clinic, a private hospital, where he underwent a scheduled procedure due to an enlarged prostate, Buckingham ...

Teleflex (NYSE:TFX) reported new research from controlled and real-world studies of Prostatic Urethral Lift (PUL) procedure with its UroLift System to treat men with benign prostatic hyperplasia (BPH) ...

WAYNE, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that new clinical data from numerous studies of the UroLift ® System for patients with benign prostatic ...